Recent Advances of Light/Hypoxia‐Responsive Azobenzene in Nanomedicine Design

Azobenzene (Azo) and its derivatives are versatile stimuli‐responsive molecules. Their reversible photoisomerization and susceptibility to reduction‐mediated cleavage make them valuable for various biomedical applications. Upon exposure to the UV light, Azo units undergo a thermodynamically stable trans‐to‐cis transition, which can be reversed by heating in the dark or irradiation with visible light. Additionally, the N=N bonds in azobenzenes can be cleaved under hypoxic conditions by azoreductase, making azobenzenes useful as hypoxia‐responsive linkers. The integration of azobenzenes into nanomedicines holds promise for enhancing therapeutic efficacy, particularly in tumor targeting and controllable drug release. In this Concept paper, recent advances in the design and applications of azobenzene‐based nanomedicines are updated, and future development opportunities are also summarized.